J Korean Knee Soc.  2011 Mar;23(1):27-32. 10.5792/jkks.2011.23.1.27.

An Autotransfusion Device Reduces the Amount of Allogenic Transfusion in Bilateral Sequential Total Knee Arthroplasty

Affiliations
  • 1Department of Orthopedic Surgery, Soonchunhyang University School of Medicine, Bucheon, Korea. sang158@hanmail.net

Abstract

PURPOSE
This study examined the difference in the reduction of the amount of required allogenic transfusion after bilateral total knee arthroplasty when an autotransfusion device was used.
MATERIALS AND METHODS
The subjects were ninety five patients who underwent sequential bilateral total knee arthroplasty from January 2006 to May 2010 by one surgeon. The first group was 50 patients who did not have an autotransfusion device used and second group of 45 patients were those who had an autotransfusion device used during the postoperative period. Group 1 received allogenic blood transfusion with a standard level of postoperative hemoglobin. The group 2 patients were reinfused with as much blood as was collected by an autotransfusion suction bag and then they received allogenic blood transfusion with a standard level of postoperative hemoglobin.
RESULTS
The total blood loss and amount of blood transfusion were almost the same in the two groups. The mean amount of allotransfusion was 1,270.0 mL in group 1 and 564.4 mL in group 2 and the reduced amount of allotransfusion in group 2 was statistically significant (p<0.05).
CONCLUSION
Using an autotransfusion device is a good method to reduce the mean amount of allotransfusion after bilateral sequential total knee arthroplasty.

Keyword

Knee; Bilateral total knee arthroplasty; Autotransfusion device; Allogenic transfusion

MeSH Terms

Arthroplasty
Blood Transfusion
Blood Transfusion, Autologous
Hemoglobins
Humans
Knee
Postoperative Period
Suction
Hemoglobins
Full Text Links
  • JKKS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr